REMEDIUM

В феврале 2017 г. в России стартовал эксперимент по маркировке ЛС - новой системе контроля, позволяющей эффективно противодействовать незаконному обороту ЛС на территории страны. О том, как сегодня реализуется этот проект и каковы уже полученные результаты, мы попросили рассказать Михаила МУРАШКО, руководителя Федеральной службы по надзору в сфере здравоохранения.

The agenda of the PharmASI Russian Pharmaceutical Forum held on May 15-16, 2018 in St. Petersburg highlighted the current issues of the Russian pharmaceutical market. Today, the key issues include getting the balance of various interests of market participants and identifying the market drivers. The main issues of international companies on the Russian market are related to enforcement of intellectual property rights, which is setting in favor of Russian companies. The unfavourable economic situation in the country causes a slowdown of growth rates on the Russian pharmaceutical market. The key market driver for the period until 2024 is the national healthcare project announced in the presidential decree in May 2018.

According to the World Health Organization (WHO), The worldwide prevalence of obesity has nearly tripled since 1975. In 2016, 39% of people over 18 years were overweight, and 13% were obese. It's not that the problem is not conceived by the society. WHO specialists have prepared a strategy to prevent and manage obesity, official medicine recognizes overweight as one of the corrected risk factors for many diseases and overweight is the leading cause of morbidity and mortality next to smoking that can be eliminated. The population is also worried about maintaining a healthy weight and health, as evidenced by almost 3 million search terms per month that contain the words "losing weight" in Yandex. Why is humanity gaining the total body weight so quickly and cannot stop? Are there any real ways to slow down this process both at the individual and at the population level?

Ulcerative colitis (UC) is an idiopathic chronic relapsing inflammatory disease of the large intestine, leading to disability of working-age people [1-3]. Due to the growth of urbanization and economic development, there is a rapid increase in the incidence of UC in the industrialized countries. According to the forecasts, the increase in morbidity will require the restructuring of medical care to the patients with this pathology [4].

The Ministry of Industry and Trade of the Russian Federation has been carrying out inspections of the foreign pharmaceutical manufacturers since April 2016. The inspectorate checks the foreign manufacturer's compliance with the Russian standards of Good Manufacturing Practice (GMP). Inspection is a key element in assessing the compliance of pharmaceutical manufacturers with GMP requirements. Nearly all the inspections identify discrepancies or violations that are documented in the inspection report and serve as a basis for taking regulatory actions such as the decision to issue a GMP-certificate or refuse to issue it, an order to eliminate discrepancies /violations, suspend or cancel a license, a marketing authorization, prohibition of manufacture, etc.

The prevention of healthcare-associated infections (HCAI) is one of the global problems worldwide in the present-day settings. According to the World Health Organization (WHO), neither type of healthcare facility in any country can claim to be free from the risk of HCAI. There are many reasons for the development of HCAI; however, the poor material and technical resources of healthcare facilities can be a key component for its development. In this regard, the quality sterilization and disinfection of the equipment is one of the most important ways to fight the HCAI.

The rating was prepared using the state accounting data of about 70 leading pharmaceutical manufacturers.

Analysis of the financial status of pharmaceutical companies is performed using state statistical reporting form No. P-3 Information on Company Financial Status (monthly).

The monthly review provides an analysis of court practice pertaining to the production and circulation of medical products to help industry specialists avoid mistakes in solving similar problems.